Initial experience in the diagnosis and treatment of superficial bladder tumors with Hexvix®;Experiencia inicial en el diagnóstico y tratamiento del tumor vesical superficial con Hexvix®

Archivos Espanoles de Urologia

Volumn 61, Issue 4, 2008, Pages 475-482

  Abascal Junquera, Jose María ^a   Suárez, Miguel Hevia ^a   Abascal García, José M ^a   Estébanez, Cristina ^a   Astudillo, Aurora ^a   Abascal, Ramón ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Diagnosis; Hexvix ; Superficial bladder cancer

Indexed keywords

5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; CARBON; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

AGED; ARTICLE; BLADDER TUMOR; CYSTOSCOPY; FEMALE; FLUORESCENCE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARBON RADIOISOTOPES; CYSTOSCOPY; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 45849140911     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. NATIONAL CANCER INSTITUTE OF THE NATIONAL INSTITUTES OF HEALTH.: "PDQ screening and prevention for patients: Screening for bladder cancer". http://cancernet.nci.nih.gov/ clinpdq/soa/Bladder_cancer_P.html. 1999.
2. BRAY, F.; SANKILA, R.; FERLAY, J. y cols.: "Estimates of cancer incidence and mortality in Europe in 1995". Eur. J. Cancer., 38: 99, 2002.
3. HERR, H.W.: "Natural history of superficial bladder tumors: 10 to 20 year follow up of treated patients". World J. Urol., 15: 84, 1997.
4. JOCHAM, D.; STEPP, H.; WAIDELICH, R.: "Photodynamic diagnosis in Urology: State of the art". Eur. Urol., 2008 (pendiente de publicación).
5. WHITMORE, W.F. Jr.; BUSH, I.M.; ESQUIVEL, E.: "Tetracycline ultraviolet fluorescence in bladder carcinoma". Cancer, 17: 1528, 1964.
6. VICENTE, J.; CHECHILE, G.; ALGABA, F.: "Value of in vivo Mucosa-Staining Test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder". Eur. Urol., 13: 15, 1987.
7. BENSON, R.C.; FARROW, G.M.; KINSEY, J.H. y cols.: "Detection and localization of in situ carcinoma of the bladder with hematoporphyrin derivate". Mayo Clin. Proc., 57: 548, 1982.
8. KRIEGMAIR, M.; BAUMGARTNER, R.; KNÜCHEL, R. y cols.: "Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid". Urology, 44: 836, 1994.
9. BATTLE, A.M.: "Porphyrins, porphyries, cancer and photodynamic therapy, a model for carcinogenesis". J. Photochem. Photobiol. B., 20: 5, 1993.
10. DANILTCHENKO, D.I.; RIEDL, C.R.; SACHS, M.D. y cols.: "Long-term Benedit of 5-aminolevulinic acid fluorescente assisted transurethral resection of superficial bladder cancer: 5 year results of a prospective randomized study". J. Urol., 174: 2129, 2005.
11. DENZINGER, S.; BURGER, M.; WALTER, B. y cols.: "Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescente diagnosis: 8 year results of prospective randomized study". Urology, 69: 675, 2007.
12. D'HALLEWIN, M.A.; KAMUHABWA, A.R.; ROSKAMS, T. y cols.: "Hypericin-based fluorescence diagnosis of bladder carcinoma". BJU Int., 89: 760, 2002.
13. SIM, H.G.; LAU, W.; OLIVO, M. y cols.: "Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?". BJU Int., 95: 1215, 2005.
14. FOTITOS, N.; CAMPO, M.A.; POPOWYCZ, F. y cols.: "5- Aminolevulinic acid derivates in photomedicine: characteristics, application and perspectives". Photochem. Photobiol., 82: 994, 2006.
15. ABASCAL, R.: "Diagnostico por fluorescencia en tumores vesicales". Arch. Esp. Urol., 60: 495, 2007.
16. ZAAK, D.; KRIEGMAIR, M.; STEPP, H. y cols.: "Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: Results of 1012 fluorescence endoscopies". Urology, 57: 590, 2001.
17. JICHLINSKI, P.; GUILLOU, L.; KARLSEN, S.J. y cols.: "Hexyl aminolevulinate fluorescence cystoscopy: A new diagnostic tool for the photodiagnosis of superficial bladder cancer, a multicentre study". J. Urol., 170: 226, 2003.
18. SCHMIDBAUER, J.; WITJES, F.; SCHMELLER, N. y cols.: "Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy". J. Urol., 171: 135, 2004.
19. JOCHAM, D.; WITJES, F.; WAGNER, S. y cols.: "Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: A prospective, phase III multicenter study". J. Urol., 174: 862, 2005.
20. GROSSMAN, H.B.; GOMILLA, L.; FRADET, Y. y cols.: "A phase III, multicenter comparison of hexaminolevulinate fluorescente cystoscopy and white cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer". J. Urol., 178: 62, 2007.
21. FRADET, Y.; GROSSMAN, H.B.; GOMELLA, L. y cols.: "A phase III, multicenter comparison of hexaminolevulinate fluorescente cystoscopy and white cystoscopy for the detection of carcinoma in situ in patients with bladder cancer". J. Urol., 178: 68, 2007.
22. VAN DER MEIJDEN, A.; OESTERLINCK, W.; BRAUSI, M. y cols.: "Significance of bladder biopsias in Ta, T1 bladder tumors: A report from the EORTC Genito-Urinary Tract Cancer Cooperative group". Eur. Urol., 35: 267, 1999.